ObsEva (NASDAQ:OBSV) Earns Hold Rating from Analysts at StockNews.com

StockNews.com initiated coverage on shares of ObsEva (NASDAQ:OBSV) in a report issued on Friday morning. The brokerage issued a hold rating on the stock.

ObsEva Trading Down 15.5 %

OBSV stock opened at $0.10 on Friday. ObsEva has a twelve month low of $0.08 and a twelve month high of $2.14. The company has a market capitalization of $7.94 million, a P/E ratio of -0.11 and a beta of 0.68. The firm has a 50 day simple moving average of $0.01 and a 200-day simple moving average of $0.04.

About ObsEva

ObsEva SA is a clinical-stage biopharmaceutical company, which engages in the research and development of therapeutic treatments for women’s reproductive health and pregnancy. It offers biopharmaceutical drugs addressing conditions compromising pregnancy from conception to birth. The company was founded by Ernest Loumaye and André Chollet on November 14, 2012 and is headquartered in Geneva, Switzerland.